ORIGINAL RESEARCH article

Front. Nutr.

Sec. Nutrition, Psychology and Brain Health

Volume 12 - 2025 | doi: 10.3389/fnut.2025.1579986

This article is part of the Research TopicNutrition and Mood DisordersView all 8 articles

A1 protein free milk benefits mood and subjective cognition in freeliving Australian adults: a pragmatic, open label, and exploratory randomised controlled trial

Provisionally accepted
  • 1FOODiQ Global, Sydney, Australia
  • 2Macquarie University, Sydney, New South Wales, Australia
  • 3The University of Newcastle, Callaghan, New South Wales, Australia

The final, formatted version of the article will be published soon.

Background: Adverse effects of milk containing A1-type β-casein on digestion, immune response, and cognition have been identified in milk-intolerant individuals, but health effects in healthy individuals without symptoms of milk intolerance are yet to be examined. Objective: The objective was to explore the impact of reducing A1 type β-casein intake via switching milk type from conventional A1/A2-type β-casein milk (A1/A2 milk) to A1-type β-casein protein free milk (A1PF) on brain, immune response, gastrointestinal, and skin (BIGS) outcomes in a realworld setting.Methods: An open-label, pragmatic, exploratory randomised controlled trial was conducted in 997 healthy, free-living Australian older adolescents and adults (16-65 years) who regularly consume A1/A2 protein-containing milk and milk products. Participants were randomised into two groups, to consume ≥250 mL/day of A1/A2 milk (control) or to switch to ≥250 mL/day of A1PF milk (intervention) for 28 days, while continuing to follow their usual diet (including up to 1 serve a day of A1/A2 dairy products). A sub-group of 265 participants conducted stool, saliva and cognitive testing on days 0 and 28. All participants completed subjective questionnaires on days 0, 14, and 28. Results: No differences in gut microbiome composition, alpha-diversity, or function were found by switching milk type. After switching to A1PF milk, a small increase in stool consistency was reported (-0.16, p=0.007), and females experienced a marginal reduction in gastrointestinal symptoms (p=0.015) and improved subjective cognition (p=0.03). Switching to A1PF milk reduced anxiety (-0.61; p=0.002), depression (-0.56; p=0.023), stress (-0.70, p=0.012) and fatigue (p=0.001; females only), compared to drinking A1/A2 milk, with stronger effects in females. No consistent effects on markers of immune response or skin health were identified. Conclusions: Switching from conventional A1/A2 milk to A1PF milk may benefit mood and subjective cognition, particularly in females, without the need for complete elimination of A1 βcasein from the diet. Further investigations are warranted.

Keywords: A1 protein free milk, Brain health, mood, Mental Health, Gastrointestinal microbiome, β-casein, brain-gut axis, pragmatic clinical trial

Received: 19 Feb 2025; Accepted: 15 May 2025.

Copyright: © 2025 Starck, Blumfield, Petocz, Duve, Downey, Abbott and Fayet-Moore. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Carlene S Starck, FOODiQ Global, Sydney, Australia
Flávia Fayet-Moore, FOODiQ Global, Sydney, Australia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.